Literature DB >> 9140748

Superparamagnetic iron oxide enhanced magnetic resonance imaging of rat liver with hepatocellular carcinoma and benign hyperplastic nodule.

T Ishida1, T Murakami, N Kato, M Takahashi, T Miyazawa, K Tsuda, K Tomoda, Y Narumi, H Nakamura.   

Abstract

RATIONALE AND
OBJECTIVES: The authors assess the potential of a new superparamagnetic iron oxide (SPIO) in grading hepatocellular carcinoma (HCC) histologically and in differentiating HCC from benign hyperplastic nodule (HPN).
METHODS: Nine Wistar rats (with poorly to moderately differentiated HCC, well-differentiated HCC, and HPN) received drinking water containing N-nitrosomorpholine, and were examined by magnetic resonance imaging (4.7 tesla). Spin-echo images (repetition time/echo time, 600/24.5 mseconds) were obtained before and 15 minutes after intravenous administration of 10 mumol Fe/kg of SH U 555A.
RESULTS: Poorly to moderately differentiated and well-differentiated HCC showed no significant change in signal-to-noise ratio (SNR) 15 minutes after contrast, whereas HPN showed a significant decrease in SNR. The contrast-to-noise ratio (CNR) between each kind of tumor and adjacent liver parenchyma showed a significant increase at 15 minutes after contrast.
CONCLUSIONS: The SPIO discussed in this article may help to differentiate HCC from HPN, but it remains difficult to grade hepatocellular carcinoma histologically.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140748     DOI: 10.1097/00004424-199705000-00005

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  2 in total

1.  [Establishment of hepatocellular carcinoma model by allogenic transplantation ].

Authors:  J Qian; G Feng; J Trübenbach; P E Huppert; P L Pereira; C D Claussen
Journal:  J Tongji Med Univ       Date:  2001

2.  SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.

Authors:  Seong Hyun Kim; Won Jae Lee; Hyo K Lim; Cheol Keun Park
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.